CAR T-Cell Therapy for Multiple Myeloma

CAR T-cell therapy (or chimeric antigen receptor therapy) is a relatively new type of treatment where cells are taken from your body and engineered to specifically recognize and attack multiple myeloma. This therapy can now be used for multiple myeloma that has not responded well to other treatments.

CAR T-Cell Therapy - What You Need to Know

SEE MORE   

  • CAR T-cells are immune cells that doctors remove from your body and re-engineer to target and destroy multiple myeloma
  • These cells are removed from your blood, genetically altered, and returned to you
  • This type of treatment can now be used for multiple myeloma that has not responded well to other treatments

CAR T-Cell Therapy - What You Need to Know

  • CAR T-cells are immune cells that doctors remove from your body and re-engineer to target and destroy multiple myeloma
  • These cells are removed from your blood, genetically altered, and returned to you
  • This type of treatment can now be used for multiple myeloma that has not responded well to other treatments
Full width image
Full width image
Full width image

Side Effects of CAR T-Cell Therapy

SEE MORE   

  • CAR T-cell therapy can cause side effects, some of which can be serious
  • Cytokine release syndrome (or CRS) is the most common side effect and causes flu-like symptoms
  • The brain can also be affected, which may lead to confusion
  • Doctors closely monitor for side effects after treatment, and have therapies to manage them

Side Effects of CAR T-Cell Therapy

  • CAR T-cell therapy can cause side effects, some of which can be serious
  • Cytokine release syndrome (or CRS) is the most common side effect and causes flu-like symptoms
  • The brain can also be affected, which may lead to confusion
  • Doctors closely monitor for side effects after treatment, and have therapies to manage them

The Treatment Plan

SEE MORE   

  • More than 100 medical centers in the US offer CAR T-cell therapy for multiple myeloma and other blood cancers
  • Currently, the treatment is approved for relapsed or refractory disease that has not responded well to at least four other treatments
  • Clinical trials are ongoing to see if the treatment can be used earlier in the treatment process

The Treatment Plan

  • More than 100 medical centers in the US offer CAR T-cell therapy for multiple myeloma and other blood cancers
  • Currently, the treatment is approved for relapsed or refractory disease that has not responded well to at least four other treatments
  • Clinical trials are ongoing to see if the treatment can be used earlier in the treatment process
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.